AQST PDUFA decision: a neutral outcome, -0.7%

On July 31, 2026, Aquestive Therapeutics, Inc. reached its PDUFA decision. The result was a neutral outcome, and the stock moved -0.7% in the window around the event. It had already run -11.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.